- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Healius Ltd (HLS)
Healius Ltd stock price live, this page displays ASX HLS stock exchange data. View the HLS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Healius Ltd real time stock price chart below.
What Is the Healius Ltd Stock Price Today?
The Healius Ltd stock price today is 0.430.
What Is the Stock Symbol for Healius Ltd?
The stock symbol for Healius Ltd is "HLS."
What Stock Exchange Does Healius Ltd Trade On?
Healius Ltd is listed and trades on the Sydney stock exchange.
Is Healius Ltd a Good Stock to Buy?
Determining whether Healius Ltd, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HLS quote. (ISIN: AU0000033359)
What Is the Healius Ltd Stock Price Today?
The Healius Ltd stock price today is 0.430.
What Is the Stock Symbol for Healius Ltd?
The stock symbol for Healius Ltd is "HLS."
What Stock Exchange Does Healius Ltd Trade On?
Healius Ltd is listed and trades on the Sydney stock exchange.
Is Healius Ltd a Good Stock to Buy?
Determining whether Healius Ltd, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HLS quote. (ISIN: AU0000033359)
Sydney
Currency in AUD
0.430
+0.005(+1.18%)
Closed·
Fair Value
An estimate of a Primary Health Care's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.418
0.435
52 wk Range
0.300
1.070
HLS is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Primary Health Care's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.4180.435
52 wk Range
0.3001.070
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
HLS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Primary Health Care's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Neutral
Price Target
0.547
Upside
+27.30%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
Primary health receives Investment Bank Analyst Rating Update- Investing.com
Pro
Primary health receives Investment Bank Analyst Rating Update- Investing.com
Pro
Primary health receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Primary health receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Primary health receives Investment Bank Analyst Rating Update- Investing.com
Pro
Primary health receives Investment Bank Analyst Rating Update- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
2 Buy
4 Hold
4 Sell
Ratings:
10 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 0.547
(+27.30% Upside)
Healius Ltd Earnings Call Summary for H2/2026
- Healius reported FY26 revenue of AUD 1.37B (+2.1%) and EBIT of AUD 30.2M (+76.6%), driven by pricing mix and cost cuts.
- Company recorded AUD 332M goodwill impairment and shifted to net debt of AUD 32.8M from prior year net cash position.
- FY27 EBIT guidance of AUD 39.7M includes AUD 15M Fair Work Commission wage impact; expects positive cash flow ahead.
- Digital transformation largely complete with 80%+ episodes on Medway platform; AI and automation tools now in production.
- Shares fell 3.37% to $0.43 despite beat, pressured by weak GP trends, telehealth shift, and contract losses in hospital segment.
Last Updated: 19/08/2026, 02:42
Read Full TranscriptEarnings
Latest Release
Aug 18, 2026
EPS / Forecast
-- / 7.68
Revenue / Forecast
-- / 971M
Compare HLS to Peers and Sector
Metrics to compare | HLS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHLSPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.8x | 20.5x | −0.4x | |
PEG Ratio | 0.00 | 0.05 | 0.00 | |
Price/Book | 1.8x | 1.7x | 2.6x | |
Price / LTM Sales | 0.2x | 1.2x | 3.1x | |
Upside (Analyst Target) | 2.8% | 20.2% | 49.0% | |
Fair Value Upside | Unlock | 18.1% | 7.0% | Unlock |
Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories and patient collection centers. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Primary Health Care (HLS) Stock Price Today?
The Primary Health Care stock price today is 0.430 AUD.
What Stock Exchange Does Primary Health Care Trade On?
Primary Health Care is listed and trades on the Sydney Stock Exchange.
What Is the Stock Symbol for Primary Health Care?
The stock symbol for Primary Health Care is "HLS."
What Is the Primary Health Care Market Cap?
As of today, Primary Health Care market cap is 310.790M AUD.
What Is Primary Health Care's Earnings Per Share (TTM)?
The Primary Health Care EPS (TTM) is -0.563.
When Is the Next Primary Health Care Earnings Date?
Primary Health Care will release its next earnings report on Oct 22, 2026.
From a Technical Analysis Perspective, Is HLS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Primary Health Care Stock Split?
Primary Health Care has split 2 times.
How Many Employees Does Primary Health Care Have?
Primary Health Care has 6000 employees.
What is the current trading status of Primary Health Care (HLS)?
As of Sep 02, 2026, Primary Health Care (HLS) is trading at a price of 0.430 AUD, with a previous close of 0.430 AUD. The stock has fluctuated within a day range of 0.418 AUD to 0.435 AUD, while its 52-week range spans from 0.300 AUD to 1.070 AUD.
What Is Primary Health Care (HLS) Price Target According to Analysts?
The average 12-month price target for Primary Health Care is 0.547 AUD, with a high estimate of 1.3 AUD and a low estimate of 0.37 AUD. 2 analysts recommend buying the stock, while 4 suggest selling, leading to an overall rating of Neutral. The stock has an +27.30% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.